Show simple item record

dc.contributor.authorHuse, JT
dc.contributor.authorSnuderl, M
dc.contributor.authorJones, DTW
dc.contributor.authorBrathwaite, CD
dc.contributor.authorAltman, N
dc.contributor.authorLavi, E
dc.contributor.authorSaffery, R
dc.contributor.authorSexton-Oates, A
dc.contributor.authorBlumcke, I
dc.contributor.authorCapper, D
dc.contributor.authorKarajannis, MA
dc.contributor.authorBenayed, R
dc.contributor.authorChavez, L
dc.contributor.authorThomas, C
dc.contributor.authorSerrano, J
dc.contributor.authorBorsu, L
dc.contributor.authorLadanyi, M
dc.contributor.authorRosenblum, MK
dc.date.accessioned2020-12-18T03:15:22Z
dc.date.available2020-12-18T03:15:22Z
dc.date.issued2017-03-01
dc.identifierpii: 10.1007/s00401-016-1639-9
dc.identifier.citationHuse, J. T., Snuderl, M., Jones, D. T. W., Brathwaite, C. D., Altman, N., Lavi, E., Saffery, R., Sexton-Oates, A., Blumcke, I., Capper, D., Karajannis, M. A., Benayed, R., Chavez, L., Thomas, C., Serrano, J., Borsu, L., Ladanyi, M. & Rosenblum, M. K. (2017). Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway. ACTA NEUROPATHOLOGICA, 133 (3), pp.417-429. https://doi.org/10.1007/s00401-016-1639-9.
dc.identifier.issn0001-6322
dc.identifier.urihttp://hdl.handle.net/11343/255694
dc.description.abstractEpileptogenic tumors affecting children and young adults are a morphologically diverse collection of neuroepithelial neoplasms that, as a group, exhibit varying levels of glial and/or neuronal differentiation. Recent advances in molecular profiling technology, including comprehensive DNA sequencing and methylation analysis, have enabled the application of more precise and biologically relevant classification schemes to these tumors. In this report, we describe a morphologically and molecularly distinct epileptogenic neoplasm, the polymorphous low-grade neuroepithelial tumor of the young (PLNTY), which likely accounts for a sizable portion of oligodendroglioma-like tumors affecting the pediatric population. Characteristic microscopic findings most notably include infiltrative growth, the invariable presence of oligodendroglioma-like cellular components, and intense immunolabeling for cluster of differentiation 34 (CD34). Moreover, integrative molecular profiling reveals a distinct DNA methylation signature for PLNTYs, along with frequent genetic abnormalities involving either B-Raf proto-oncogene (BRAF) or fibroblast growth factor receptors 2 and 3 (FGFR2, FGFR3). These findings suggest that PLNTY represents a distinct biological entity within the larger spectrum of pediatric, low-grade neuroepithelial tumors.
dc.languageEnglish
dc.publisherSPRINGER
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.titlePolymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway
dc.typeJournal Article
dc.identifier.doi10.1007/s00401-016-1639-9
melbourne.affiliation.departmentPaediatrics (RCH)
melbourne.affiliation.departmentMedicine (RMH)
melbourne.affiliation.facultyMedicine, Dentistry & Health Sciences
melbourne.source.titleActa Neuropathologica
melbourne.source.volume133
melbourne.source.issue3
melbourne.source.pages417-429
dc.rights.licenseCC BY
melbourne.elementsid1197500
melbourne.contributor.authorSaffery, Richard
melbourne.contributor.authorSexton-Oates, Alexandra
dc.identifier.eissn1432-0533
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record